Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone

W. S. Dalton, Anne E Cress, David S Alberts, J. M. Trent

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

A human colon carcinoma cell line selected for a 21-fold resistance to mixtoxantrone was cross-resistant to the anthracycline, doxorubicin, but not to the anthracene, bisantrene. A 2-fold resistance was observed with vinblastine, another drug associated with multidrug resistance. Net intracellular mitoxantrone and doxorubicin accumulation were decreased at 1 h for all dose levels in the resistant cell line compared to the sensitive cell line. Although the resistant cells were more resistant to mitoxantrone than doxorubicin, the net accumulation of mitoxantrone was only 19% less than the sensitive cell line; whereas doxorubicin accumulation was decreased by 49%. No significant difference between the sensitive and resistant cell lines was observed in the initial accumulation of mitoxantrone; however, the efflux of mitoxantrone was increased in the resistant cell line. Verapamil did not overcome the resistance to mitoxantrone and did not increase the net accumulation of drug. No alterations in the electrophoretic mobility of membrane proteins were observed. Using immunoblotting techniques, the resistant cell line did not express P-glycoprotein which is frequently observed for cells resistant to anthracycline antibiotics. Cytogenetic analysis showed a putative homogenously staining region on the short arm of chromosome 7 in the resistant cell line. The limited cross-resistant phenotype, lack of verapamil reversal, nondetection of P-glycoprotein, and cytogenetic evidence of gene amplification suggests the involvement of a novel drug-resistant gene associated with resistance to mitoxantrone.

Original languageEnglish (US)
Pages (from-to)1882-1888
Number of pages7
JournalCancer Research
Volume48
Issue number7
StatePublished - 1988

Fingerprint

Mitoxantrone
Cytogenetic Analysis
Colon
Carcinoma
Cell Line
Doxorubicin
Anthracyclines
bisantrene
P-Glycoprotein
Verapamil
Pharmaceutical Preparations
Chromosomes, Human, Pair 7
Vinblastine
Gene Amplification
Multiple Drug Resistance
Immunoblotting
Cytogenetics
Membrane Proteins
Staining and Labeling
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. / Dalton, W. S.; Cress, Anne E; Alberts, David S; Trent, J. M.

In: Cancer Research, Vol. 48, No. 7, 1988, p. 1882-1888.

Research output: Contribution to journalArticle

@article{371d068f581f4bb89dd75f4a075f4818,
title = "Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone",
abstract = "A human colon carcinoma cell line selected for a 21-fold resistance to mixtoxantrone was cross-resistant to the anthracycline, doxorubicin, but not to the anthracene, bisantrene. A 2-fold resistance was observed with vinblastine, another drug associated with multidrug resistance. Net intracellular mitoxantrone and doxorubicin accumulation were decreased at 1 h for all dose levels in the resistant cell line compared to the sensitive cell line. Although the resistant cells were more resistant to mitoxantrone than doxorubicin, the net accumulation of mitoxantrone was only 19{\%} less than the sensitive cell line; whereas doxorubicin accumulation was decreased by 49{\%}. No significant difference between the sensitive and resistant cell lines was observed in the initial accumulation of mitoxantrone; however, the efflux of mitoxantrone was increased in the resistant cell line. Verapamil did not overcome the resistance to mitoxantrone and did not increase the net accumulation of drug. No alterations in the electrophoretic mobility of membrane proteins were observed. Using immunoblotting techniques, the resistant cell line did not express P-glycoprotein which is frequently observed for cells resistant to anthracycline antibiotics. Cytogenetic analysis showed a putative homogenously staining region on the short arm of chromosome 7 in the resistant cell line. The limited cross-resistant phenotype, lack of verapamil reversal, nondetection of P-glycoprotein, and cytogenetic evidence of gene amplification suggests the involvement of a novel drug-resistant gene associated with resistance to mitoxantrone.",
author = "Dalton, {W. S.} and Cress, {Anne E} and Alberts, {David S} and Trent, {J. M.}",
year = "1988",
language = "English (US)",
volume = "48",
pages = "1882--1888",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone

AU - Dalton, W. S.

AU - Cress, Anne E

AU - Alberts, David S

AU - Trent, J. M.

PY - 1988

Y1 - 1988

N2 - A human colon carcinoma cell line selected for a 21-fold resistance to mixtoxantrone was cross-resistant to the anthracycline, doxorubicin, but not to the anthracene, bisantrene. A 2-fold resistance was observed with vinblastine, another drug associated with multidrug resistance. Net intracellular mitoxantrone and doxorubicin accumulation were decreased at 1 h for all dose levels in the resistant cell line compared to the sensitive cell line. Although the resistant cells were more resistant to mitoxantrone than doxorubicin, the net accumulation of mitoxantrone was only 19% less than the sensitive cell line; whereas doxorubicin accumulation was decreased by 49%. No significant difference between the sensitive and resistant cell lines was observed in the initial accumulation of mitoxantrone; however, the efflux of mitoxantrone was increased in the resistant cell line. Verapamil did not overcome the resistance to mitoxantrone and did not increase the net accumulation of drug. No alterations in the electrophoretic mobility of membrane proteins were observed. Using immunoblotting techniques, the resistant cell line did not express P-glycoprotein which is frequently observed for cells resistant to anthracycline antibiotics. Cytogenetic analysis showed a putative homogenously staining region on the short arm of chromosome 7 in the resistant cell line. The limited cross-resistant phenotype, lack of verapamil reversal, nondetection of P-glycoprotein, and cytogenetic evidence of gene amplification suggests the involvement of a novel drug-resistant gene associated with resistance to mitoxantrone.

AB - A human colon carcinoma cell line selected for a 21-fold resistance to mixtoxantrone was cross-resistant to the anthracycline, doxorubicin, but not to the anthracene, bisantrene. A 2-fold resistance was observed with vinblastine, another drug associated with multidrug resistance. Net intracellular mitoxantrone and doxorubicin accumulation were decreased at 1 h for all dose levels in the resistant cell line compared to the sensitive cell line. Although the resistant cells were more resistant to mitoxantrone than doxorubicin, the net accumulation of mitoxantrone was only 19% less than the sensitive cell line; whereas doxorubicin accumulation was decreased by 49%. No significant difference between the sensitive and resistant cell lines was observed in the initial accumulation of mitoxantrone; however, the efflux of mitoxantrone was increased in the resistant cell line. Verapamil did not overcome the resistance to mitoxantrone and did not increase the net accumulation of drug. No alterations in the electrophoretic mobility of membrane proteins were observed. Using immunoblotting techniques, the resistant cell line did not express P-glycoprotein which is frequently observed for cells resistant to anthracycline antibiotics. Cytogenetic analysis showed a putative homogenously staining region on the short arm of chromosome 7 in the resistant cell line. The limited cross-resistant phenotype, lack of verapamil reversal, nondetection of P-glycoprotein, and cytogenetic evidence of gene amplification suggests the involvement of a novel drug-resistant gene associated with resistance to mitoxantrone.

UR - http://www.scopus.com/inward/record.url?scp=0023897681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023897681&partnerID=8YFLogxK

M3 - Article

C2 - 2894893

AN - SCOPUS:0023897681

VL - 48

SP - 1882

EP - 1888

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 7

ER -